title: Increasing antimicrobial resistance and narrowing therapeutics in typhoidal salmonellae.
abstract: Multidrug-resistant typhoid fever (MDRTF) is a major public health problem in developing countries and is an emerging problem in the developed world. Because of the difficulties in preventing typhoid by public health measures or immunization in developing countries, great reliance is placed on antimicrobial chemotherapy. The treatment should commence as soon as the clinical diagnosis is made rather than after the results of antimicrobial susceptibility tests but the existence of MDRTF poses a serious clinical dilemma in the selection of empiric antimicrobial therapy. With the widespread emergence and spread of strains resistant to chloramphenicol, ampicillin and trimethoprim, ciprofloxacin became the drug of choice for the treatment of typhoid fever. However, of late the efficacy of fluoroquinolones too has been questioned, mainly due to increasing reports of increasing defervescence time and poor patient response. This indicates that the organism has begun to develop resistance to fluoroquinolones, and is corroborated by a steady increase in Minimum Inhibitory Concentration (MIC) of ciprofloxacin. The therapeutics of ciprofloxacin-resistant enteric fever narrows down to third- and fourth-generation cephalosporins and azithromycin. However, the emergence of extended-spectrum b-lactamases (ESBLs) in typhoidal Salmonellae poses a new challenge and would greatly limit the therapeutic options leaving only tigecycline and carbepenems as secondary antimicrobial drugs. This increasing resistance is alarming and emphasizes the need of effective preventive measures to control typhoid and to limit the unnecessary use of antibiotics.
authors: Assistant Professor, Department of Microbiology Institution Punjab Institute of Medical Sciences , Jalandhar, India .
authors: Jaspal
authors: J
authors: Kaurthe
keywords: Antimicrobial resistance; cephalosporins; extended-spectrum b-lactamases; quinolones, typhoidal salmonellae
references: Int J Infect Dis. 2006 Nov;10(6):434-8
references: 16978898
references: Indian J Med Microbiol. 2006 Jan;24(1):45-8
references: 16505555
references: Trop Doct. 2009 Jan;39(1):28-30
references: 19211419
references: J Infect Dev Ctries. 2008 Aug 30;2(4):253-9
references: 19741285
references: Emerg Infect Dis. 2010 Jul;16(7):1170-1
references: 20587199
references: Indian J Med Sci. 1994 Apr;48(4):85-8
references: 8076992
references: J Clin Microbiol. 2006 Oct;44(10):3811-3
references: 17021117
references: Indian J Med Res. 2009 Jan;129(1):95-8
references: 19287065
references: Lancet. 1990 Jul 28;336(8709):252
references: 1973803
references: Antimicrob Agents Chemother. 1973 Dec;4(6):597-601
references: 4602828
references: Int J Infect Dis. 2007 Jul;11(4):337-41
references: 17321180
references: Emerg Infect Dis. 2005 Jan;11(1):172-4
references: 15714664
references: J Infect Dev Ctries. 2010 Mar 08;4(2):70-3
references: 20212336
references: J Antimicrob Chemother. 2005 Jun;55(6):846-52
references: 15872047
references: Scand J Infect Dis. 1990;22(4):505-6
references: 2218413
references: Indian J Med Microbiol. 2007 Jan;25(1):78-9
references: 17377367
references: Nature. 1972 Sep 8;239(5367):109-10
references: 4562109
references: Int J Infect Dis. 2008 Nov;12(6):e143-4
references: 18514007
references: Indian J Med Microbiol. 2008 Jan-Mar;26(1):50-3
references: 18227598
references: Antimicrob Agents Chemother. 2008 Apr;52(4):1278-84
references: 18212096
references: J Med Microbiol. 2007 Nov;56(Pt 11):1490-1494
references: 17965350
references: Pathol Microbiol (Basel). 1967;30(1):71-93
references: 5182856
references: Indian J Med Microbiol. 2006 Apr;24(2):101-6
references: 16687859
references: Indian J Med Res. 2004 Aug;120(2):111-4
references: 15347861
references: Ann Trop Med Parasitol. 1995 Oct;89(5):515-9
references: 7495365
references: JAMA. 1975 Jan 13;231(2):162-6
references: 1172682
references: Braz J Infect Dis. 2002 Dec;6(6):281-7
references: 12585971
references: Br Med J. 1972 Aug 5;3(5822):329-31
references: 4558307
references: J Med Microbiol. 2009 Mar;58(Pt 3):337-341
references: 19208884
references: Indian J Med Sci. 1999 Nov;53(11):486-9
references: 10862271
references: Lancet. 1981 May 30;1(8231):1181-3
references: 6112529
references: Mutat Res. 1967 Mar-Apr;4(2):119-27
references: 5340975
references: Lancet. 1990 Oct 27;336(8722):1065-6
references: 1977034
references: Zhonghua Yi Xue Za Zhi. 1991 Jun;71(6):314-7, 24
references: 1667493
references: Lancet. 1991 Feb 23;337(8739):498
references: 1671505
references: Emerg Infect Dis. 2001 Jul-Aug;7(4):762-3
references: 11585550